Why Amazon's $6.5 billion chip deal with Astera Labs is a ‘double-edged sword'

Core Viewpoint - Astera Labs' shares declined despite exceeding fourth-quarter earnings expectations, as investors expressed skepticism regarding the value of a significant deal with Amazon [1] Group 1: Earnings Performance - Astera Labs reported a fourth-quarter earnings beat, indicating stronger-than-expected financial performance [1] Group 2: Investor Sentiment - Investors raised concerns about the rationale behind the large deal with Amazon, leading to a drop in share prices [1]